BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2819882)

  • 1. Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions.
    Eghbali M; Santoro C; Paredes W; Gardner EL; Zukin RS
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6582-6. PubMed ID: 2819882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra.
    Smith JA; Leslie FM; Broide RS; Loughlin SE
    Neuroscience; 1993 Aug; 55(4):935-51. PubMed ID: 8232904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrete mapping of brain Mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors.
    Sharif NA; Hughes J
    Peptides; 1989; 10(3):499-522. PubMed ID: 2550910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutral endopeptidase-24.11, mu and delta opioid receptors after selective brain lesions: an autoradiographic study.
    Waksman G; Hamel E; Delay-Goyet P; Roques BP
    Brain Res; 1987 Dec; 436(2):205-16. PubMed ID: 2829989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution.
    Caboche J; Rogard M; Besson MJ
    Brain Res Dev Brain Res; 1991 Jan; 58(1):111-22. PubMed ID: 1849802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of brain lesions on [3H]ohmefentanyl binding site densities in the rat striatum and substantia nigra.
    Masuo Y; Wang H; Pélaprat D; Chi ZQ; Rostène W
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2520-4. PubMed ID: 1332831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography.
    Tempel A; Zukin RS
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4308-12. PubMed ID: 3035579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of opioid receptors in rat nucleus accumbens following mesolimbic dopaminergic lesions.
    Unterwald EM; Tempel A; Koob GF; Zukin RS
    Brain Res; 1989 Dec; 505(1):111-8. PubMed ID: 2558779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and opiate receptors: localization in the striatum and evidence for their axoplasmic transport in the nigrostriatal and striatonigral pathways.
    Van der Kooy D; Weinreich P; Nagy JI
    Neuroscience; 1986 Sep; 19(1):139-46. PubMed ID: 2431346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum.
    Masuo Y; Pélaprat D; Scherman D; Rostène W
    Neurosci Lett; 1990 Jun; 114(1):45-50. PubMed ID: 1974339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of the mu-opiate receptor patches in the rat neostriatum following lesioning of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+): restoration by embryonic nigral dopamine grafts.
    Sirinathsinghji DJ; Dunnett SB
    Brain Res; 1989 Dec; 504(1):115-20. PubMed ID: 2557122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in striatal mu and delta opioid receptors after transient forebrain ischemia: a quantitative autoradiographic study.
    Benfenati F; Pich EM; Zoli M; Grimaldi R; Fuxe K; Agnati LF
    Brain Res; 1991 Apr; 546(1):171-5. PubMed ID: 1649667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptor changes in weaver mouse striatum.
    Loughlin SE; An A; Leslie FM
    Brain Res; 1992 Jul; 585(1-2):149-55. PubMed ID: 1324769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid binding sites in the nigrostriatal system of the guinea pig are not located on nigral dopaminergic neurons.
    Foote RW; Maurer R
    Neurosci Lett; 1986 Apr; 65(3):341-5. PubMed ID: 3012421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nigral 6-hydroxydopamine lesions equally decrease mu and delta opiate binding to striatal patches: further evidence for a conformationally malleable type 1 opiate receptor.
    Bowen WD; Pert CB; Pert A
    Life Sci; 1982 Oct 18-25; 31(16-17):1679-82. PubMed ID: 6296571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
    Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
    Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ; Millan MJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of opioid peptides and receptors in striatum and substantia nigra during rat brain development.
    Winzer-Serhan UH; Chen Y; Leslie FM
    J Chem Neuroanat; 2003 Aug; 26(1):17-36. PubMed ID: 12954528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
    Johansson PA; Andersson M; Andersson KE; Cenci MA
    Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.